has announced the completion of a $20.2 million seed financing round and the formation of a Scientific Advisory Board (SAB) to drive forward its innovative thymus cell therapy platform.

“On behalf of the investor syndicate and the board, we congratulate the Montara team, which has made exceptional progress and achieved all the R&D goals of the original seed round, a culmination ...

Syndicate strengthened with new investors and increased commitments from all existing investors. Total Series Seed funding reaches $28M to advance lead epilepsy program to IND, progress ...

Total Series Seed funding reaches $28M to advance lead epilepsy program to IND, progress neurodegeneration program to development candidate (DC), and accelerate a third undisclosed program. Troy ...